ReP USP - Resultado da busca

Artigo de periodico
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2023)
Weir, Ashley; Kang, Eun-Young; Meagher, Nicola S.; Nelson, Gregg S.; Ghatage, Prafull; Lee, Cheng-Han; Riggan, Marjorie J.; Ryan, Andy; Singh, Naveena; Alsop, Jennifer; Anglesio, Michael S.; Bisinoto, Christiani; Ramus, Susan J. ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: BIOMARCADORES, ADENOCARCINOMA, NEOPLASIAS OVARIANAS, PROGNÓSTICO, RNA MENSAGEIRO, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEIR, Ashley et al. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, v. 128, n. 1, p. 137-147, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41416-022-02014-y. Acesso em: 18 nov. 2024.
APA
Weir, A., Kang, E. -Y., Meagher, N. S., Nelson, G. S., Ghatage, P., Lee, C. -H., et al. (2023). Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, 128( 1), 137-147. doi:10.1038/s41416-022-02014-y
NLM
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Vancouver
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Artigo de periodico
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2022)
Kang, Eun-Young; Millstein, Joshua; Popovic, Gordana; Meagher, Nicola S.; Bolithon, Adelyn; Talhouk, Aline; Chiu, Derek S.; Anglesio, Michael S.; Leung, Betty; Tang, Katrina; Lambie, Neil; Pavanello, Marina; Ramus, Susan J.; Köbel, Martin; Reis, Francisco José Candido dos
Source: Virchows Archiv. Unidade: FMRP
Subjects: BIOMARCADORES, PROLIFERAÇÃO CELULAR, NEOPLASIAS OVARIANAS, RNA MENSAGEIRO, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANG, Eun-Young et al. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, v. 480, n. 4, p. 855-871, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00428-021-03232-0. Acesso em: 18 nov. 2024.
APA
Kang, E. -Y., Millstein, J., Popovic, G., Meagher, N. S., Bolithon, A., Talhouk, A., et al. (2022). MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, 480( 4), 855-871. doi:10.1007/s00428-021-03232-0
NLM
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00428-021-03232-0
Vancouver
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00428-021-03232-0
Artigo de periodico
Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings (2022)
Millward, Christopher P.; Armstrong, Terri S.; Barrington, Heather; Bell, Sabrina; Brodbelt, Andrew R.; Bulbeck, Helen; Crofton, Anna; Dirven, Linda; Islim, Abdurrahman I.; Tirapelli, Daniela Pretti da Cunha ; Carlotti Júnior, Carlos Gilberto
Source: BMJ Open. Unidade: FMRP
Subjects: TÉCNICA DELPHI, NEOPLASIAS MENÍNGEAS, PROJETOS DE PESQUISA, REVISÃO SISTEMÁTICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILLWARD, Christopher P. et al. Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ Open, v. 12, n. 5, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2021-057384. Acesso em: 18 nov. 2024.
APA
Millward, C. P., Armstrong, T. S., Barrington, H., Bell, S., Brodbelt, A. R., Bulbeck, H., et al. (2022). Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ Open, 12( 5), 1-14. doi:10.1136/bmjopen-2021-057384
NLM
Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Islim AI, Tirapelli DP da C, Carlotti Júnior CG. Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings [Internet]. BMJ Open. 2022 ; 12( 5): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1136/bmjopen-2021-057384
Vancouver
Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Islim AI, Tirapelli DP da C, Carlotti Júnior CG. Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings [Internet]. BMJ Open. 2022 ; 12( 5): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1136/bmjopen-2021-057384
Artigo de periodico
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study (2021)
Nepogodiev, Dmitri; Alonso, Nivaldo ; Santos, Carlos Ferreira dos ; Tonello, Cristiano ; Duarte, Geraldo; Joviliano, Edwaldo Edner; Santos, Carolina Lourenço Gomes dos; Quintana, Silvana Maria; Tamashiro, Edwin ; Valera, Fabiana Cardoso Pereira ; Zaccaro, Marília Veccechi Bijos; Gregorio, Paulo; Mariani, Alessandro Wasum; Minamoto, Fabio; Carvalho, Vladimir C.; Lima, Ana Lucia Munhoz; Oliveira, Priscila R.; Silva, Jorge dos Santos; Murta, Claudio Bovolenta; Salgado Júnior, Wilson; Prado, Caio Antonio de Campos; Moisés, Elaine Christine Dantas ; Suto, Hilda Satié; Yasuda, Alice Gadotti; Kowalski, Luiz Paulo
Source: Anaesthesia: Peri-operative medicine, critical care and pain. Unidades: HRAC, FOB, FMRP, FM, ESALQ
Subjects: COVID-19, IDOSOS, JOVENS, CRIANÇAS EM IDADE PRÉ-ESCOLAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEPOGODIEV, Dmitri et al. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia: Peri-operative medicine, critical care and pain, v. 76, n. 6, p. 748-758, 2021Tradução . . Disponível em: https://doi.org/10.1111/anae.15458. Acesso em: 18 nov. 2024.
APA
Nepogodiev, D., Alonso, N., Santos, C. F. dos, Tonello, C., Duarte, G., Joviliano, E. E., et al. (2021). Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia: Peri-operative medicine, critical care and pain, 76( 6), 748-758. doi:10.1111/anae.15458
NLM
Nepogodiev D, Alonso N, Santos CF dos, Tonello C, Duarte G, Joviliano EE, Santos CLG dos, Quintana SM, Tamashiro E, Valera FCP, Zaccaro MVB, Gregorio P, Mariani AW, Minamoto F, Carvalho VC, Lima ALM, Oliveira PR, Silva J dos S, Murta CB, Salgado Júnior W, Prado CA de C, Moisés ECD, Suto HS, Yasuda AG, Kowalski LP. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study [Internet]. Anaesthesia: Peri-operative medicine, critical care and pain. 2021 ; 76( 6): 748-758.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/anae.15458
Vancouver
Nepogodiev D, Alonso N, Santos CF dos, Tonello C, Duarte G, Joviliano EE, Santos CLG dos, Quintana SM, Tamashiro E, Valera FCP, Zaccaro MVB, Gregorio P, Mariani AW, Minamoto F, Carvalho VC, Lima ALM, Oliveira PR, Silva J dos S, Murta CB, Salgado Júnior W, Prado CA de C, Moisés ECD, Suto HS, Yasuda AG, Kowalski LP. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study [Internet]. Anaesthesia: Peri-operative medicine, critical care and pain. 2021 ; 76( 6): 748-758.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/anae.15458
Artigo de periodico
The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas (2020)
Pinto, Filipe; Costa, Ângela M.; Santos, Gisele C.; Matsushita, Marcus M.; Costa, Sandra; Silva, Viviane A. O.; Miranda‐Gonçalves, Vera; Lopes, Celeste M.; Clara, Carlos A.; Becker, Aline P.; Neder, Luciano ; Hajj, Gláucia N. M.; Cunha, Isabela W. da; Jones, Chris; Andrade, Raquel P.; Reis, Rui M.
Source: The Journal of Pathology. Unidade: FMRP
Assunto: GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Filipe et al. The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas. The Journal of Pathology, v. 251, n. 1, p. 87-99, 2020Tradução . . Disponível em: https://doi.org/10.1002/path.5419. Acesso em: 18 nov. 2024.
APA
Pinto, F., Costa, Â. M., Santos, G. C., Matsushita, M. M., Costa, S., Silva, V. A. O., et al. (2020). The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas. The Journal of Pathology, 251( 1), 87-99. doi:10.1002/path.5419
NLM
Pinto F, Costa ÂM, Santos GC, Matsushita MM, Costa S, Silva VAO, Miranda‐Gonçalves V, Lopes CM, Clara CA, Becker AP, Neder L, Hajj GNM, Cunha IW da, Jones C, Andrade RP, Reis RM. The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas [Internet]. The Journal of Pathology. 2020 ; 251( 1): 87-99.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/path.5419
Vancouver
Pinto F, Costa ÂM, Santos GC, Matsushita MM, Costa S, Silva VAO, Miranda‐Gonçalves V, Lopes CM, Clara CA, Becker AP, Neder L, Hajj GNM, Cunha IW da, Jones C, Andrade RP, Reis RM. The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas [Internet]. The Journal of Pathology. 2020 ; 251( 1): 87-99.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/path.5419
Artigo de periodico
External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis (2020)
Snell, Kym I. E.; Allotey, John; Smuk, Melanie; Hooper, Richard; Chan, Claire; Ahmed, Asif; Chappell, Lucy C.; Von Dadelszen, Peter; Green, Marcus; Kenny, Louise; Khalil, Asma; Costa, Fabrício da Silva
Source: BMC Medicine. Unidade: FMRP
Subjects: PRÉ-ECLÂMPSIA, DIAGNÓSTICO, COMPLICAÇÕES NA GRAVIDEZ, PROGNÓSTICO, REPRODUTIBILIDADE DE RESULTADOS, AVALIAÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNELL, Kym I. E. et al. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis. BMC Medicine, v. 18, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12916-020-01766-9. Acesso em: 18 nov. 2024.
APA
Snell, K. I. E., Allotey, J., Smuk, M., Hooper, R., Chan, C., Ahmed, A., et al. (2020). External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis. BMC Medicine, 18. doi:10.1186/s12916-020-01766-9
NLM
Snell KIE, Allotey J, Smuk M, Hooper R, Chan C, Ahmed A, Chappell LC, Von Dadelszen P, Green M, Kenny L, Khalil A, Costa F da S. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis [Internet]. BMC Medicine. 2020 ; 18[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12916-020-01766-9
Vancouver
Snell KIE, Allotey J, Smuk M, Hooper R, Chan C, Ahmed A, Chappell LC, Von Dadelszen P, Green M, Kenny L, Khalil A, Costa F da S. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis [Internet]. BMC Medicine. 2020 ; 18[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12916-020-01766-9

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration